Endoscopic Submucosal Dissection Market by Product (Cap & Hood, Forceps & Clips, Gastroscopes & Colonoscopes), Indication (Colon & Rectum Cancer, Esophageal Cancer, Stomach Cancer), End User - Global Forecast 2024-2030

[197 Pages Report] The Endoscopic Submucosal Dissection Market size was estimated at USD 320.68 million in 2023 and expected to reach USD 339.99 million in 2024, at a CAGR 6.95% to reach USD 513.38 million by 2030.

A minimally invasive procedure, endoscopic submucosal dissection (ESD) removes precancerous and cancerous areas of the gastrointestinal (GI) tract using a flexible, tube-like tool called an endoscope. Endoscopic submucosal dissection (ESD) may be more effective than endoscopic mucosal resection (EMR) for removing certain cancerous cell growths, particularly those without clear borders or those too large to remove in one piece using other methods. The rising cases of cancer, significant preference for minimally invasive surgeries, and favorable reimbursement policies have enhanced the adoption of ESD procedures. However, the associated adverse impacts and requirement of huge amounts of money may hinder the development of the market. Nevertheless, the emerging approvals and ongoing technological advancements in endoscopic submucosal dissection can create lucrative prospects for the market in the forecast period.

Endoscopic submucosal dissection procedures have lower mortality and morbidity rates and higher patient quality of life than alternative surgical procedures, such as EMR. As a result, ESD has become a well-established procedure in Asian countries, such as Japan, South Korea, India, and China. Moreover, Japan and South Korea have reported the highest rate of stomach cancer, which has increased the adoption of ESD procedures. Japan is also considered a central hub for training sessions for the ESD procedures. Thus, Asia-Pacific countries have covered the large spectrum of the ESD market. Similarly, European countries are increasingly practicing ESD procedures due to rising cases of cancers and a significant preference for minimally invasive surgeries. The presence of adequate healthcare infrastructure, skilled healthcare professionals, and advanced technologies have bolstered the development of the ESD market. Favorable reimbursement scenarios, training opportunities, device availability, and a highly successful ratio have widened the ESD market scope in the American region. According to the American Cancer Society, stomach cancer accounts for approximately 1.5% of all new cancers diagnosed in the United States each year, which has increased the use of ESD procedures.

The market dynamics represent an ever-changing landscape of the Endoscopic Submucosal Dissection Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

• Market Drivers
  • Growing geriatric population coupled with rising incidences of cancer
  • Favorable reimbursement policies for endoscopic procedures
  • Growing adoption of minimally invasive surgeries across the globe
• Market Restraints
  • High capital and maintenance cost of endoscopic submucosal dissection procedures
• Market Opportunities
  • Increasing number of approvals for endoscopic submucosal dissection techniques
  • Technological advancements in endoscopic submucosal dissection techniques and devices
• Market Challenges
  • Side effects associated with postoperative infection of endoscopic submucosal dissection procedures

The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Endoscopic Submucosal Dissection Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Endoscopic Submucosal Dissection Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Endoscopic Submucosal Dissection Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

• Olympus in $370M buy of Taewoong to expand in gastrointestinal endotherapy field

  Olympus, a renowned manufacturer of medical and surgical equipment and systems, has recently committed to purchasing Taewoong Medical Co. to the tune of $370 million in order to expand its presence in the Endoscopic Submucosal Dissection (ESD) market. The acquisition is expected to provide Olympus with enhanced experience and capabilities within this specialized field and give them greater access to research opportunities as well as innovative treatments for gastrointestinal procedures. Through this purchase, Olympus aims to expand their presence across Asia Pacific and other global markets, increasing their production in support of Taewoong's existing supply chain. With an expected completion date set for 1Q 2021, this move contains all the ingredients for a successful venture that should serve the industry well. [Published On: February 27, 2023]

• Fujifilm expands endoscopy solutions for gastrointestinal applications

  Fujifilm has recently announced the expansion of their endoscopy solutions for gastroenterology applications like Endoscopic Submucosal Dissection (ESD). The latest enhancements to their product lineup include a range of tools including improved integrated imaging technologies and advanced endoscopic blades. Furthermore, the advancements also focus on offering a suite of cost-efficient solutions that are designed to meet the professional needs of gastroenterologists. With these improvements, practitioners can now expect expanded procedural capabilities that include higher efficiency and better visualization when performing ESD procedures. This new product assortment is sure to be a great asset for any medical center looking to bolster their endoscopic offerings and provide better care for their patients. [Published On: January 10, 2023]

• Olympus Announces EMEA Expansion of Exclusive Partnership with EndoClot Plus, Inc.

  Olympus is proud to announce their expansion of the exclusive partnership with Endoclot Plus, Inc. to provide the European, Middle Eastern and African (EMEA) markets with significant advances in endoscopic submucosal dissection tissue management using proprietary bipolar-discharge technology. Olympus has been leading the industry in developing innovative products for over a century, and this latest venture is yet another example of this forward-thinking progress. With Endoclot’s cutting-edge product strategy, customers will now have access to the highest quality endoscopy products available on the market. This combination of Olympus' decades of experience paired with Endoclot's mission to optimize tissue resection performance stands to bring about unprecedented outcomes for EMEA patients seeking advanced treatments for gastrointestinal illnesses. [Published On: December 08, 2022]

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Endoscopic Submucosal Dissection Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

The report delves into recent significant developments in the Endoscopic Submucosal Dissection Market, highlighting leading vendors and their innovative profiles. These include Advanced Endoscopy Devices, Inc., Ambu A/S, Angelus Medical and Optical, Anrei Medical, Aohua Endoscopy Co., Ltd., Aspen Surgical, Avante Medical Surgical, Beijing ZKSK Technology Co., Ltd., Boston Scientific Corporation, ConMed Corporation, Cook Group Incorporated, Creo Medical, Duomed Group, EndoMed Systems GmbH, Endoss GmbH, Erbe Elektromedizin GmbH, Etsy, Inc., Flexicare Medical Ltd., Fujifilm Holdings Corporation, Guangzhou Happycare Electronics Co., Ltd., Hangzhou AGS MedTech Co., Ltd., HMB Endoscopy Products, Hoya Corporation, Huger Medical Instrument Co., Ltd., Interscope, Inc., Jiangsu Maslech Medical Technology Co., Ltd., Jiangsu Vedkang Medical Science and Technology Co., Ltd., Karl Storz SE & Co. KG, Lenox Instrument Company, Leo Medical Co. Ltd., Medi-Globe GmbH by DCC Healthcare, MedTec Applications, Inc., Medtronic PLC, Micro-Tech Endoscopy, MicroAire Surgical Instruments, LLC, Mizuho America, Inc., MTW-Endoskopie W. Haag KG, Olympus Corporation, Optim LLC, Ovesco Endoscope AG, Port Macquarie Gastroenterology, Pride Medical Instruments Technology Jiangsu Co., Ltd., Richard Wolf Industrial, SonoScape Medical Corp., Steris Corporation, Sumitomo Bakelite Co., Ltd., Taewoong Medical, The Surgical Company, Vector Medical, and Zeon Medical Inc..

This research report categorizes the Endoscopic Submucosal Dissection Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Cap & Hood
  • Forceps & Clips
  • Gastroscopes & Colonoscopes
  • Knives
    • Dual
    • Flex
    • Hook
    • Insulation-tipped
    • Needle
    • Triangle-tipped
• Indication
  • Colon & Rectum Cancer
  • Esophageal Cancer
  • Stomach Cancer
• End User
  • Ambulatory Surgical Centres
  • Hospitals
  • Specialty Clinics

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

1. What is the current market size and projected growth?
2. Which products, segments, applications, and regions offer promising investment opportunities?
3. What are the prevailing technology trends and regulatory frameworks?
4. What is the market share and positioning of the leading vendors?
5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?